Clarithromycin Drug Study
Clarithromycin Drug Study
Clarithromycin Drug Study
antibiotic Therapeutic actions Inhibits protein synthesis in susceptible bacteria, causing cell death Indications Treatment of upper respiratory infections caused by S. pyogenes, S. pneumonia > Treatment of lower respiratory infections caused by Mycoplasmapneumoniae, S. pneumoniae, H. influenzae, M. catarrhalis >Treatment of skin and structure infections caused by S. aureus, S.pyogenes >Treatment of disseminated mycobacterial infections due to M.avium and M. intracellular >Treatment of active duodenal ulcer with H. pylori in combination with proton pump inhibitor > Treatment of acute otitis media, acute maxillary sinusitis due to H.influenzae, M. cararrhalis, S. pneumonia > Treatment of mild to moderate community-acquired pneumonia in adults (ER tablets)
Contra-indications